229 related articles for article (PubMed ID: 37393341)
1. Renal interferon-inducible protein 16 expression is associated with disease activity and prognosis in lupus nephritis.
Wang X; Fu S; Yu J; Ma F; Zhang L; Wang J; Wang L; Tan Y; Yi H; Wu H; Xu Z
Arthritis Res Ther; 2023 Jul; 25(1):112. PubMed ID: 37393341
[TBL] [Abstract][Full Text] [Related]
2. Interferon-Inducible Protein 10 and Disease Activity in Systemic Lupus Erythematosus and Lupus Nephritis: A Systematic Review and Meta-Analysis.
Puapatanakul P; Chansritrakul S; Susantitaphong P; Ueaphongsukkit T; Eiam-Ong S; Praditpornsilpa K; Kittanamongkolchai W; Avihingsanon Y
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31597273
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-32γ: Possible association with the activity and development of nephritis in patients with systemic lupus erythematosus.
Kwon OC; Ghang B; Lee EJ; Hong S; Lee CK; Yoo B; Kim S; Kim YG
Int J Rheum Dis; 2019 Jul; 22(7):1305-1311. PubMed ID: 30941928
[TBL] [Abstract][Full Text] [Related]
4. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
[TBL] [Abstract][Full Text] [Related]
5. Serum uric acid as a predictor for nephritis in Egyptian patients with systemic lupus erythematosus.
Hafez EA; Hassan SAE; Teama MAM; Badr FM
Lupus; 2021 Mar; 30(3):378-384. PubMed ID: 33323012
[TBL] [Abstract][Full Text] [Related]
6. Predicting diagnostic gene expression profiles associated with immune infiltration in patients with lupus nephritis.
Wang L; Yang Z; Yu H; Lin W; Wu R; Yang H; Yang K
Front Immunol; 2022; 13():839197. PubMed ID: 36532018
[TBL] [Abstract][Full Text] [Related]
7. Human neutrophil peptide 1-3, a component of the neutrophil extracellular trap, as a potential biomarker of lupus nephritis.
Cheng FJ; Zhou XJ; Zhao YF; Zhao MH; Zhang H
Int J Rheum Dis; 2015 Jun; 18(5):533-40. PubMed ID: 25196784
[TBL] [Abstract][Full Text] [Related]
8. Urinary ferritin creatinine ratio, a potential biomarker for lupus nephritis activity.
Qi L; Xu J; Yang C; Hou X; Yang P
Clin Rheumatol; 2021 Jan; 40(1):143-149. PubMed ID: 32557256
[TBL] [Abstract][Full Text] [Related]
9. Discovery of NEU1 as a candidatedone. renal biomarker for proliferative lupus nephritis chronicity.
Mao Z; Tan Y; Yu F; Zhao M
Lupus Sci Med; 2021 Dec; 8(1):. PubMed ID: 34872988
[TBL] [Abstract][Full Text] [Related]
10. Validity of immunoglobulin-binding protein 1 as a biomarker for lupus nephritis.
Ebaid AM; Ezzeldin N; Abdelhady EI; Mohammed HA; Abdallah AL
Lupus; 2023 Jan; 32(1):101-110. PubMed ID: 36418233
[TBL] [Abstract][Full Text] [Related]
11. Renal mTORC1 activation is associated with disease activity and prognosis in lupus nephritis.
Mao Z; Tan Y; Tao J; Li L; Wang H; Yu F; Perl A; Zhao M
Rheumatology (Oxford); 2022 Aug; 61(9):3830-3840. PubMed ID: 35040950
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor binding protein-2 as a biomarker for lupus nephritis.
Luong PT; Nguyen TTD; Nguyen NT; Ngo HT; Nguyen HN; Pho DH; Nguyen HT
Pediatr Int; 2023; 65(1):e15613. PubMed ID: 37698235
[TBL] [Abstract][Full Text] [Related]
13. Circulating exosomal microRNAs as biomarkers of lupus nephritis.
Chen F; Shi B; Liu W; Gong J; Gao J; Sun Y; Yang P
Front Immunol; 2023; 14():1326836. PubMed ID: 38223506
[TBL] [Abstract][Full Text] [Related]
14. The role of cyclic GMP-AMP synthase and Interferon-I-inducible protein 16 as candidatebiomarkers of systemic lupus erythematosus.
Fu Q; He Q; Dong Q; Xie J; Geng Y; Han H; Huang Y; Lu J; Zeng Z; Wang W; Chen K; Zhan X
Clin Chim Acta; 2022 Jan; 524():69-77. PubMed ID: 34742679
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor binding protein-2 as a novel biomarker for disease activity and renal pathology changes in lupus nephritis.
Ding H; Kharboutli M; Saxena R; Wu T
Clin Exp Immunol; 2016 Apr; 184(1):11-8. PubMed ID: 26616478
[TBL] [Abstract][Full Text] [Related]
16. Serum thiols as a biomarker of disease activity in lupus nephritis.
Lalwani P; de Souza GK; de Lima DS; Passos LF; Boechat AL; Lima ES
PLoS One; 2015; 10(3):e0119947. PubMed ID: 25799079
[TBL] [Abstract][Full Text] [Related]
17. Urine ALCAM, PF4 and VCAM-1 Surpass Conventional Metrics in Identifying Nephritis Disease Activity in Childhood-Onset Systemic Lupus Erythematosus.
Soliman SA; Haque A; Vanarsa K; Zhang T; Ismail F; Lee KH; Pedroza C; Greenbaum LA; Mason S; Hicks MJ; Wenderfer SE; Mohan C
Front Immunol; 2022; 13():885307. PubMed ID: 35720325
[TBL] [Abstract][Full Text] [Related]
18. Circulating miR-181a and miR-223 expression with the potential value of biomarkers for the diagnosis of systemic lupus erythematosus and predicting lupus nephritis.
Abdul-Maksoud RS; Rashad NM; Elsayed WSH; Ali MA; Kamal NM; Zidan HE
J Gene Med; 2021 May; 23(5):e3326. PubMed ID: 33617143
[TBL] [Abstract][Full Text] [Related]
19. Serum uric acid as a sensitive concordant marker with lupus nephritis and new onset of renal damage: a prospective cohort study.
Elnady B; Almalki A; Abdel-Fattah MM; Desouky DE; Attar M
Clin Rheumatol; 2021 May; 40(5):1827-1834. PubMed ID: 33094396
[TBL] [Abstract][Full Text] [Related]
20. Urinary dedifferentiated podocytes as a non-invasive biomarker of lupus nephritis.
Perez-Hernandez J; Olivares MD; Forner MJ; Chaves FJ; Cortes R; Redon J
Nephrol Dial Transplant; 2016 May; 31(5):780-9. PubMed ID: 26932688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
